Carotenoids from marine microalgae: A valuable natural source for the prevention of chronic diseases

Marine Drugs

Volumn 13, Issue 8, 2015, Pages 5128-5155

  De Jesus Raposo, Maria Filomena ^a   De Morais, Alcina Maria Miranda Bernardo ^a   De Morais, Rui Manuel Santos Costa ^a  

^a UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

Author keywords

Aging; Astaxanthin; Carotenoids; Chronic diseases; Free radicals; Fucoxanthin; Inflammatory diseases; Marine microalga; Oxidative stress; RNS; ROS; carotene

Indexed keywords

ASTAXANTHIN; BETA CAROTENE; CANTHAXANTHIN; CAROTENOID; ECHINENONE; FUCOXANTHIN; VIOLAXANTHIN; XANTHOPHYLL; ZEAXANTHIN; ANTIOXIDANT; BIOLOGICAL PRODUCT;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL PROTECTION; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); CONCENTRATION RESPONSE; DIABETES MELLITUS; DISEASE CONTROL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; LIPID PEROXIDATION; MICROALGA; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REGULATORY MECHANISM; REVIEW; ANIMAL; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL PRODUCTS; CAROTENOIDS; CHRONIC DISEASE; HUMANS; MICROALGAE; OXIDATIVE STRESS;

EID: 84940416355     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13085128     Document Type: Review

References (170)

1. Durackova, Z. Some current insights into oxidative stress. Physiol. Res. 2010, 59, 459-469.
2. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010, 49, 1603-1616.
3. Pashkow, F. J. Oxidative stress and inflammation in heart disease: Do antioxidants have a role in treatment and/or prevention? Int. J. Inflam. 2011, 2011, doi:10.4061/2011/514623.
4. Kalam, S.; Gul, M. Z.; Singh, R.; Ankati, S. Free radicals: Implications in etiology of chronic diseases and their amelioration through nutraceuticals. Pharmacologia 2015, 6, 11-20.
5. Kirkham, P. Oxidative stress and macrophage function: A failure to resolve the inflammatory response. Biochem. Soc. Trans. 2007, 35, 284-287.
6. Rodrigues, E.; Marintti, L. R. B.; Mercadante, A. Z. Scavenging capacity of marine carotenoids against reactive oxygen and nitrogen species in a membrane-mimicking system. Mar. Drugs 2012, 10, 1784-1798.
7. Yan, L.-J. Positive oxidative stress in aging and aging-related disease tolerance. Redox Biol. 2014, 2, 165-169.
8. Baynes, J. W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40, 405-412.
9. Helmersson, J.; Arnlöv, J.; Larsson, A.; Basu, S. Low dietary intake of β-carotene, a-tocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort. Br. J. Nutr. 2009, 101, 1775-1782.
10. Bian, Q.; Gao, S.; Zhou, J.; Qin, J.; Taylor, A.; Johnson, E. J.; Tanq, G.; Sparrow, J. R.; Gierhart, D.; Shanq, F. Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic. Biol. Med. 2012, 53, 1298-1307.
11. Riccioni, G. Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep. 2009, 11, 434-439.
12. Bhatt, D. L. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Am. J. Cardiol. 2008, 101, 4-13.
13. Fassett, R. G.; Coombes, J. S. Astaxanthin: A potential therapeutic agent in cardiovascular disease. Mar. Drugs 2011, 9, 447-465.
14. Gross, G. J.; Hazen, S. L.; Lockwood, S. F. Seven day oral supplementation with Cardax (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats. Mol. Cell. Biochem. 2006, 283, 23-30.
15. Speranza, L.; Pesce, M.; Patruno, A.; Fransceschelli, S.; De Lutiis, M. A.; Grilli, A.; Felaco, M. Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar. Drugs 2012, 10, 890-899.
16. Britton, G. Structure and properties of carotenoids in relation to function. FASEB J. 1995, 9, 1551-1558.
17. Lavy, A.; Naveh, Y.; Coleman, R.; Mokady, S.; Werman, M. J. Dietary Dunaliella bardawil, a β-carotene-rich alga, protects against acetic acid-induced small bowel inflammation in rats. Inflamm. Bowel Dis. 2003, 9, 372-379.
18. Chidambara-Murthy, K. N.; Vanitha, A.; Rajesha, J.; Mahadeva-Swamy, M.; Sowmya, P. R.; Ravishankar, G. A. In vivo antioxidant activity of carotenoids from Dunaliella salina-A green microalga. Life Sci. 2005, 76, 1381-1390.
19. Lorenz, R. T.; Cysewski, G. R. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol. 2000, 18, 160-167.
20. +-ATPase and antioxidant enzyme activities in rats. Eur. J. Nutr. 2008, 47, 432-441.
21. Régnier, P.; Bastias, J.; Rodriguez-Ruiz, V.; Caballero-Casero, N.; Caballo, C.; Sicilia, D.; Fuentes, A.; Maire, M.; Crepin, M.; Letourneur, D.; et al. Astaxanthin from Haematococcus pluvialis prevents oxidative stress on human endothelial cells without toxicity. Mar. Drugs 2015, 13, 2857-2874.
22. Fassett, R. G.; Healy, H.; Driver, R.; Robertson, I. K.; Gesaghy, D. P.; Sharman, J. E.; Coombes, J. S. Astaxanthin vs. placebo on arterial stiffness oxidative stress and inflammation in renal transplant patients (Xanthin): A randomized controlled trial. BMC Nephrol. 2008, 9, 17.
23. Guerin, M.; Huntley, M. E.; Olaizola, M. Haematococcus astaxanthin: Applications for human health and nutrition. Trends Biotechnol. 2003, 21, 210-216.
24. Park, J. S.; Chyun, J. H.; Kim, Y. K.; Line, L. L.; Chew, B. P. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr. Metab. 2010, 5, 7-18.
25. Bobrov, Z.; Tracton, I.; Taunton, K.; Mathews, M. Effectiveness of whole dried Dunaliella salina marine microalgae in the chelating and detoxification of toxic minerals and heavy metals.. Available online: http://www.interclinical.com.au/publications/archived%20publications/DetoxPaper100308.pdf (assessed on 5 August 2014).
26. Abidov, M.; Ramazanov, Z.; Seifulla, R.; Grachev, S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic live disease and normal liver fat. Diabetes Obes. Metable. 2010, 12, 72-81.
27. Han, D.; Li, Y.; Hu, Q. Astaxanthin in microalgae: Pathways, functions and biotechnological implications. Algae 2013, 28, 131-147.
28. Sun, Z.; Liu, J.; Bi, Y.-H.; Zhou, Z.-G. Microalgae as the production platform for carotenoids. In Recent Advances in Microalgal Biotechnology; Liu, J., Sun, Z., Gerken, H., Eds.; Omics Group eBooks: Foster City, CA, USA, 2014; pp. 1-17.
29. Takaichi, S. Carotenoids in algae: Distribution, biosynthesis and function. Mar. Drugs 2011, 9, 1101-1118.
30. Dembitsky, V. M.; Maoka, T. Allenic and cumulenic lipids. Prog. Lipid Res. 2007, 46, 328-375.
31. El-Baz, F. K.; Abdoul-Enein, A. M.; El-Baroty, G.-S.; Youssef, A. M.; El-Baky, H. H. A. Accumulation of antioxidant vitamins in Dunaliella salina. J. Biol. Sci. 2002, 2, 220-223.
32. Bar, E.; Rise, M.; Vishkautsan, M.; Arad, S. Pigment and structural changes in Chlorella zofingiensis upon light and nitrogen stress. J. Plant Physiol. 1995, 146, 527-534.
33. Patel, A.; Mishr, S.; Pawar, R.; Ghosh, P. K. Purification and characterization of C-phycocyanin from cyanobacterial species of marine and freshwater habitat. Protein Express. Purif. 2005, 40, 248-255.
34. Miranda, M. S.; Cintra, R. G.; Barros, S. B.; Mancini-Filho, J. Antioxidant activity of the microalga Spirulina maxima. Braz. J. Med. Biol. Res. 1998, 31, 1075-1079.
35. El-Baky, H. H. A.; El-Baz, F. K.; El-Baroty, G.-S. Spirulina species as a source of carotenoids and a-tocopherol and its anticarcinoma factors. Biotechnology 2003, 2, 222-240.
36. Jaime, L.; Mendiola, J. A.; Herrero, M.; Soler-Rivas, C.; Santoyo, S.; Señorans, F. J.; Cifuentes, A.; Ibáñez, E. Separation and characterization of antioxidants from Spirulina platensis microalga combining pressurized liquid extraction, TLC, and HPLC-DAD. J. Sep. Sci. 2005, 28, 2111-2119.
37. Abe, K.; Hattori, H.; Hirano, M. Accumulation and antioxidant activity of secondary carotenoids in the aerial microalga Coelastrella striolata var. multistriata. Food Chem. 2007, 100, 656-661.
38. Hata, N.; Ogbonna, J. C.; Hasegawa, Y.; Taroda, H.; Tanaka, H. Production of astaxanthin by Haematococcus pluvialis in a sequential heterotrophic-photoautotrophic culture. J. Appl. Phycol. 2001, 13, 395-402.
39. Kang, C. D.; Lee, J. S.; Park, T. H.; Sim, S. J. Comparison of heterotrophic and photoautotrophic induction on astaxanthin production by Haematococcus pluvialis. Appl. Microbiol. Biotechnol. 2005, 68, 237-241.
40. Steinbrenner, J.; Linden, H. Regulation of two carotenoid biosynthesis genes coding for phytoene synthase and carotenoid hydrolase during stress-induced astaxanthin formation in the green alga Haematococcus pluvialis. Plant Physiol. 2001, 125, 810-817.
41. Nobre, B.; Marcelo, F.; Passos, R.; Beirão, L.; Palavra, A.; Gouveia, L.; Mendes, R. Supercritical carbon dioxide extraction of astaxanthin and other carotenoids from the microalga Haematococcus pluvialis. Eur. Food Res. Technol. 2006, 223, 787-790.
42. Cerón, M. C.; García-Malea, M. C.; Rivas, J.; Acien, F. G.; Fernandez, J. M.; Del Rio, E.; Guerrero, M. G.; Molina, E. Antioxidant activity of Haematococcus pluvialis cells grown in continuous culture as a function of their carotenoid and fatty acid content. Appl. Microbiol. Biotechnol. 2007, 74, 1112-1119.
43. Wu, Z.; Wu, S.; Shi, X. Supercritical fluid extraction and determination of lutein in heterotrophically cultivated Chlorella pyrenoidosa. J. Food Proc. Eng. 2007, 30, 174-185.
44. 2 extraction of carotenoids and other lipids from Chlorella vulgaris. Food Chem. 1995, 53, 99-103.
45. Cha, K. H.; Koo, S. Y.; Lee, D.-U. Antiproliferative effects of carotenoids extracted from Chlorella ellipsoidea and Chlorella vulgaris on human colon cancer cells. J. Agric. Food Chem. 2008, 56, 10521-10526.
46. Kim, S. M.; Jung Y.-J.; Kwon, O.-N.; Cha, K. H.; Um, B.-H.; Chung, D.; Pan, C.-H. A potential commercial source of fucoxanthin extracted from the microalga Phaeodactylum tricornutum. Appl. Biochem. Biotechnol. 2012, 166, 1843-1855.
47. Ragni, M.; D'Alcalá, M. R. Circadian variability in the photobiology of Phaeodactylum tricornutum: Pigment content. J. Plankton Res. 2007, 29, 141-156.
48. Dambek, M.; Eilers, U.; Breitenbach, J.; Steiger, S.; Büchel, C.; Sandmann, G. Biosynthesis of fucoxanthin and diadinoxanthin and function of initial pathway genes in Phaeodactylum tricornutum. J. Exp. Bot. 2012, 63, 5607-5612.
49. Kim, S. M.; Kang, S.-W.; Kwon, O. N.; Chung, D.; Pan, C.-H. Fucoxanthin as a major carotenoid in Isochrysis aff. galbana: Characterization of extraction for commercial application. J. Korean Soc. Appl. Biol. Chem. 2012, 55, 477-483.
50. Rijstenbil, J. W. Effects of UVB radiation and salt stress on growth, pigments and oxidative defence of the marine diatom Cylindrotheca closterium. Mar. Ecol. Prog. Ser. 2003, 254, 37-48.
51. Xia, S.; Wang, K.; Wan, L.; Li, A.; Hu, Q.; Zhang, C. Production, characterization, and antioxidant activity of fucoxanthin from the marine diatom Odontella aurita. Mar. Drugs 2013, 11, 2667-2681.
52. Schubert, N.; García-Mendoza, E.; Pacheco-Ruiz, I. Carotenoid composition of marine red algae. J. Phycol. 2006, 42, 1208-1216.
53. Tonegawa, I.; Okada, S.; Murakami, M.; Yamagushi, K. Pigment composition of the green microalga Botryococcus braunii Kawagushi-1. Fish. Sci. 1998, 64, 305-308.
54. Lichtenthaler, T. K. The 1-deoxy-D-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1999, 50, 47-65.
55. Disch, A.; Schwender, J.; Müller, C.; Lichtenthaler, H. K.; Rohmer, M. Distribution of the mevalonate and glyceraldehyde phosphate/pyruvate pathways for isoprenoid biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714. Biochem. J. 1998, 333, 381-388.
56. Miziorko, H. M. Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch. Biochem. Biophys. 2011, 505, 131-143.
57. Cunningham, F. X.; Gantt, E. Genes and enzymes of carotenoid biosynthesis in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1998, 49, 557-583.
58. Grünewald, K.; Eckert, M.; Hirschberg, J.; Hagen, C. Phytoene desaturase is localized exclusively in the chloroplast and up-regulated at the mRNA level during accumulation of secondary carotenoids in Haematococcus pluvialis (Volvocales, Chlorophyceae). Plant Physiol. 2000, 122, 1261-1268.
59. Steinbrenner, J.; Linden, H. Light induction of carotenoid biosynthesis genes in the green alga Haematococcus pluvialis: Regulation of photosynthetic redox control. Plant Mol. Biol. 2003, 52, 343-356.
60. Cunningham, F. X.; Pogson, B.; Sun, Z.; McDonald, K. A.; Della Penna, D.; Gantt, E. Functional analysis of the beta and epsilon lycopene cyclase enzymes of Arabidopsis reveals a mechanism for control of cyclic carotenoid formation. Plant Cell 1996, 8, 1613-1626.
61. Bertrand, M. Carotenoid biosynthesis in diatoms. Photosynth. Res. 2010, 106, 89-102.
62. Ayala, A.; Muñoz, M. F.; Argüelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, 2014, doi:10.115/2014/360438.
63. Halliwell, B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006, 141, 312-322.
64. Miyamoto, S.; Martinez, G. R.; Rettori, D.; Augusto, O.; Medeiros, M. H. G.; Di Mascio, P. linoleic hydroperoxide reacts with hypochlorous acid, generating peroxyl radical intermediates and singlet molecular oxygen. Proc. Natl. Acad. Sci. USA 2006, 103, 293-298.
65. Miyamoto, S.; Ronsein, G. E.; Prado, F. M.; Uemi, M.; Corrêa, T. C.; Toma, I. N.; Bertolucci, A.; Oliveira, M. C. B.; Motta, F. D.; Medeiros, M. H. G.; et al. Biological hydroperoxides and singlet molecular oxygen generation. IUBMB Life 2007, 59, 322-331.
66. Halliwell, B. Free radicals, antioxidants, and human disease: Curiosity, cause or consequence? Lancet 1994, 344, 721-724.
67. Wink, D. A.; Kasprak, K. S.; Maragos, C. M.; Elespuru, R. K.; Misra, M.; Dunams, T. M.; Cebula, T. A.; Koch, W. H.; Andrews, A. W.; Allen, J. S.; et al. DNA deaminating activity and genotoxicity of nitric oxide and its progenitors. Science 1991, 254, 1001-1003.
68. Gutowski, M.; Kowalczyk, S. A study of free radical chemistry: Their role and pathophysiological significance. Acta Biochem. Pol. 2013, 60, 1-16.
69. Kanner, J.; German, J. B.; Kinsella, J. E. Initiation of lipid peroxidation in biological systems. Crit. Rev. Food Sci. Nutr. 1987, 25, 317-364.
70. Negre-Salvayre, A.; Coatrieux, C.; Ingueneau, C.; Salvayre, R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 2008, 153, 6-20.
71. Halliwell, B.; Gutteridge, J. M. C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 1984, 219, 1-14.
72. Mezzetti, A.; Guglielmi, M. D.; Pierdomenico, S. D.; Costantini, F.; Cipollone, F.; De Cesare, D.; Bucciarelli, T.; Ucchino, S.; Chiarelli, F.; Cuccurullo, F.; et al. Increased systemic oxidative stress after elective endarterectomy. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 2659-2665.
73. Nishigaki, I.; Hagihara, M.; Tsunekawa, H.; Maseki, M.; Yagi, K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem. Med. 1981, 25, 373-378.
74. Klaunig, J. E.; Kamendulis, L. M.; Hocevar, B. A. Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol. 2010, 38, 96-109.
75. Klaunig, J. E.; Kamendulis, L. M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 2004, 44, 239-267.
76. Mezzetti, A.; Cipollone, F.; Cuccurullo, F. Oxidative stress and cardiovascular complications in diabetes: Isoprostanes as new markers on an old paradigm. Cardiovasc. Res. 2000, 47, 475-488.
77. Praticò, D.; Fitz Gerald, G. A. Generation of 8-epi prostaglandin F2a by human monocytes: Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J. Biol. Chem. 1996, 271, 8919-8924.
78. Wolff, S. P.; Dean, R. T. Glucose autoxidation and protein modification: Their potential role of autoxidative glycosylation in diabetes. Biochem. J. 1987, 245, 243-250.
79. Nourooz-Zadeh, J.; Tajaddini-Sarmadi, J.; McCarthy, S.; Betteridge, D. J.; Wolff, S. P. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995, 44, 1054-1058.
80. Poljak, K. B.; Milisav, I. Aging, oxidative stress and antioxidants. InTech 2013, 14, 331-353.
81. Giera, M.; Lingeman, H.; Niessen, W. M. A. Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): A brief overview. Chromatographia 2012, 75, 433-440.
82. Argüelles, S.; García, S.; Maldonado, M.; Machado, A.; Ayala, A. Do the serum oxidative stress biomarkers provide a reasonable index of the general oxidative stress status? Biochim. Biophys. Acta 2004, 1674, 254-259.
83. McCance, D. R.; Dyer, D. G.; Dunn, J. A.; Bailie, K. E.; Thorpe, S. R.; Baynes, J. W.; Lyons, T. J. Maillard reaction products and their relation to the complications of diabetes. J. Clin. Invest. 1993, 91, 2470-2478.
84. Wang, S. F., Yen, J. C., Yin, P. H., Chi, C. W., Lee, H. C. Involvement of oxidative stress-activated JNK signalling in the methamphetamine-induced cell death of human SH-SY5Y cells. Toxicology 2008, 246, 234-241.
85. Hasegawa, T.; Matsuzaki, M.; Takeda, A.; Kikuchi, A.; Furukawa, K.; Shibahara, S.; Itoyama, Y. Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase. J. Neurochem. 2003, 87, 470-475.
86. Liu, X.; Shibata, T.; Hisaka, S.; Osawa, T. Astaxanthin inhibits reactive oxygen species mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism. Brain Res. 2009, 1254, 18-27.
87. Aoi, W.; Naito, Y.; Sakama, K.; Kuchide, M.; Tokuda, H.; Maoka, T.; Toyokumi, S.; Oka, S.; Yasuhara, M.; Yoshikawa, T. Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid. Redox Signal. 2003, 5, 139-144.
88. Nakao, R.; Nelson, O. L.; Park, J. S.; Mathison, B. D.; Thompson, P. A.; Chew, B. P. Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Res. 2010, 30, 2721-2725.
89. Praticò, D.; Iuliano, L.; Spagnoli, L.; Mauriello, A.; Lawson, J. A.; Rokach, J.; Maclouf J.; Violi, F.; Fitz Gerald, G. A. Localization of distinct F2 isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 1997, 100, 2028-2034.
90. Praticò, D.; Barry, O. P.; Lawson, J. A.; Adiyaman, M.; Hwang, S. W.; Khanapure, S. P.; Iuliano, L.; Rokach, J.; Fitz Gerald, G. A. IPF2 a-I: An index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. USA 1998, 95, 3449-3454.
91. Guiwotta, C.; Morrow, J. D.; Roberts, L. J. I. I.; Kuhn, H. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 3236-3241.
92. Sugawara, T.; Kushiro, M.; Zhang, H.; Nara E.; Ono, H.; Nagao, A. Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. J. Nutr. 2001, 131, 2921-2927.
93. Olson, J. A. Absorption, transport, and metabolism of carotenoids in humans. Pure Appl. Chem. 1994, 66, 1011-1106.
94. Parker, R. S. Absorption, metabolism, and of transport carotenoids. FASEB J. 1996, 10, 542-551.
95. Furr, H. C.; Clark, R. M. Intestinal absorption and tissue distribution of carotenoids. J. Nutr. Biochem. 1997, 8, 364-377.
96. Elliot, R. Mechanisms of genomic and non-genomic actions of carotenoids. Biochim. Biophys. Acta 2005, 1740, 147-154.
97. Paetau, I.; Chen, H.; Goh, N. M.-Y.; White, W. S. Interactions of the postprandial appearance of β-carotene and canthaxanthin in plasma triacylglycerol-rich lipoproteins in humans. Am. J. Clin. Nutr. 1997, 66, 1133-1143.
98. Stahl, W.; Schwarz, W.; Van Laar, J.; Sies, H. All-trans-β-carotene preferentially accumulates in human chylomicron and very low density lipoproteins compared with 9-cis geometrical isomer. J. Nutr. 1995, 125, 2128-2133.
99. Krinsky, N. I.; Cornwell, D. G.; Oncley, J. L. The transport of vitamin A and carotenoids in human plasma. Arch. Biochem. Biophys. 1958, 73, 233-246.
100. Goulinet, S.; Chapman, M. J. Plasma LDL and HDL subspecies are heterogeneous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Arterioscl. Thromb. Vasc. Biol. 1997, 17, 786-796.
101. Østerlie, M.; Bjerkeng, B.; Liaan-Jensen, S. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J. Nutr. Biochem. 2000, 11, 482-490.
102. Gärtner, C.; Stahl, W.; Sies, H. Preferential increase in chylomicron levels of xanthophylls lutein and zeaxanthin compared to β-carotene in the human. Int. J. Vitamin Nutr. Res. 1996, 66, 119-125.
103. Peng, J.; Yuan, J.-P.; Wu, C.-F.; Wang, J.-H. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health. Mar. Drugs 2011, 9, 1806-1828.
104. Odeberg, J. M.; Lignell, A.; Petterson, A.; Hoglung, P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur. J. Pharm. Sci. 2003, 19, 299-304.
105. Manabe, E.; Handa, O.; Naito, Y.; Mizushima, K.; Akagiri, S.; Adachi, S.; Takagi, T.; Kokura, S.; Maoka, T.; Yoshikawa, T. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J. Cell. Biochem. 2008, 103, 1925-1937.
106. Yonekura, L.; Kobayashi, M.; Terasaki, M.; Nagao, A. Keto-carotenoids are the major metabolites of dietary lutein and fucoxanthin in mouse tissues. J. Nutr. 2010, 140, 1824-1831.
107. Hashimoto, T.; Ozaki, Y.; Taminato, M.; Das, S. K.; Mizuno, M.; Yoshimura, K.; Maoka, T.; Kanazawa, K. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. Br. J. Nutr. 2009, 102, 242-248.
108. Strand, A.; Herstad, O.; Liaaen-Jensen, S. Fucoxanthin metabolites in egg yolks of laying hens. Comp. Biochem. Phys. A Mol. Integr. Physiol. 1998, 119, 963-974.
109. Sugawara, T.; Baskaran, V.; Tsuzuki, W.; Nagao, A. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. J. Nutr. 2002, 132, 946-951.
110. Asai, A.; Sugawara, T.; Ono, H.; Nagao, A. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and Hep G2 cells: Formation and cytotoxicity of fucoxanthin metabolites. Drug Metab. Dispos. 2004, 32, 205-211.
111. Nishino, H.; Tsushima, M.; Matsuno, T.; Tanaka, Y.; Okuzumi, J.; Murakoshi, M.; Satomi, Y.; Takatasu, Y.; Tokuda, H.; Nishino, A. Anti-neoplastic effect of halocynthiaxanthin, a metabolite of fucoxanthin. Anticancer Drugs 1992, 3, 493-497.
112. Das, S. K.; Ren, R. D.; Hashimoto, T.; Kanazawa, K. Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells. J. Agric. Food Chem. 2010, 58, 6090-6095.
113. Sangeetha, R. K.; Bhaskar, N.; Baskaran, V. Comparative effects of β-carotene and fucoxanthin on retinol deficiency induced oxidative stress in rats. Mol. Cell. Biochem. 2009, 331, 59-67.
114. Rao, A. R.; Baskaran, V.; Sarada, R.; Ravishankar, G. A. In vivo bioavailability and antioxidant activity of carotenoids from microalgal biomass-A repeated dose study. Food Res. Int. 2013, 54, 711-717.
115. Ben-Amotz, A.; Levy, Y. Bioavailability of natural isomers mixture compared with synthetic all-trans β-carotene in human serum. Am. J. Clin. Nutr. 1996, 63, 729-734.
116. Okada, Y.; Ishikura, M.; Maoka, T. Bioavailability of astaxanthin in Haematococcus algal extract: The effects of timing of diet and smoking habits. Biosci. Biotechnol. Biochem. 2009, 73, 1928-1932.
117. Coral-Hinostroza, G.; Ytrestoyl, T.; Ruyter, B.; Bjerkeng, B. Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin fatty acids diesters. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2004, 139, 99-110.
118. Raposo, M. F. J.; Morais, A. M. M. B. Microalgae for the prevention of cardiovascular disease and stroke. Life Sci. 2015, 125, 32-41.
119. Miki, W. Biological functions and activities of animal carotenoids. Pure Appl. Chem. 1991, 63, 141-146.
120. Palozza, P., Krinsky, N. I. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 1992, 297, 291-295.
121. Krinsky, N. I. Antioxidant functions of carotenoids. Free Radic. Biol. Med. 1989, 7, 617-635.
122. Khan, S. K.; Malinski, T.; Mason, R. P.; Kubant, R.; Jacob, R. F.; Fujioka, K.; Denstadet, S. J.; King, T. J.; Jackson, H. L.; Hieber, A. D.; et al. Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thromb. Res. 2010, 126, 299-305.
123. Maoka, T.; Tokuda, H.; Suzuki, N.; Kato, H.; Etoh, H. Anti-oxidative, anti-tumor-promoting, anti-carcinogenesis activities of nitroastaxanthin and nitrolutein, the reaction products of astaxanthin and lutein with peroxynitrite. Mar. Drugs 2012, 10, 1391-1399.
124. Sachindra, N. M.; Sato, E.; Maeda, H.; Hosokawa, M.; Niwano, Y.; Kohno, M.; Miyashita, K. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J. Agric. Food Chem. 2007, 55, 8516-8522.
125. Burton, G. W.; Ingold, K. U. β-Carotene: An unusual type of lipid antioxidant. Science 1984, 224, 569-573.
126. Kikugawa, K.; Hiramoto, K.; Tomiyama, S.; Assano, Y. β-Carotene effectively scavenges toxic nitrogen dioxide and peroxynitrous acid. FEBS Lett. 1997, 404, 175-178.
127. Zaragozá, M. C.; López, D.; Sáiz, M. P.; Poquet, M.; Pérez, J.; Puig-Parellada, P.; Mármol, F.; Simonetti, P.; Gardana, C.; Lerat, Y.; et al. Toxicity and antioxidant activity in vitro and in vivo of two Fucus. vesiculosus extracts. J. Agric. Food Chem. 2008, 56, 7773-7780.
128. Liu, C. L.; Chin, Y. T.; Hu, M.-L. Fucoxanthin enhances HO-1 and NQO1 expression in murine hepatic BNL CL.2 cells through activation of the Nrf2/ARE system partially by its pro-oxidant activity. J. Agric. Food Chem. 2011, 59, 11344-11351.
129. Tsuboi, M.; Etoh, H.; Kato, K.; Nakatugawa, H.; Kato, H.; Maejima, Y.; Matsumoto, G.; Mori, H.; Hosokawa, M.; Miyashita, K.; et al. Nitrocapsanthin and nitrofucoxanthin, respective products of capsanthin and fucoxanthin reaction with peroxynitrite. J. Agric. Food Chem. 2011, 59, 10572-10578.
130. Yan, X.; Chuda, Y.; Suzuki, M.; Nagata, T. Fucoxanthin as the major antioxidant in Hizikia fusiformis, a common edible seaweed. Biosci. Biotechnol. Biochem. 1999, 63, 605-607.
131. Higgins, M. Risk factors associated with chronic obstructive lung disease. Ann. N. Y. Acad. Sci. 1991, 624, 7-17.
132. Nomura, T.; Kikuchi, M.; Kubodera, A.; Kawakami, Y. Proton-donative antioxidant activity of fucoxanthin with 1, 1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int. 1997, 42, 361-370.
133. Kikuchi, M.; Hirano, A.; Kunito, S.; Kawakami, Y. Fucoxanthin, an antioxidative substance from marine diatom Phaeodactylum tricornutum. J. Mar. Biotechnol. 1995, 3, 132-135.
134. Paravicini, T. M.; Touyz, R. M. NADPH oxidases, reactive oxygen species, and hypertension: Clinical inplications and therapeutic possibilities. Diabetes Care 2008, 31, 170-180.
135. 2-induced cell damage. Eur. Food Res. Technol. 2008, 228, 145-151.
136. Murakami, A.; Nakashima, M.; Koshiba, T.; Maoka, T.; Nishino, H.; Yano, M.; Sumida, T.; Kim, O. K.; Koshimizu, K.; Ohigashi, H. Modifying effects of carotenoids on superoxide and nitric oxide generation from stimulated leucocytes. Cancer Lett. 2000, 149, 115-123.
137. Pashkow, F. J.; Watumull, D. G.; Campbell, C. L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101, 58-68.
138. Shimidzu, N.; Goto, M.; Miki, W. Carotenoids as singlet oxygen quenchers in marine organisms. Fish. Sci. 1996, 62, 134-137.
139. Kurashige, M.; Okimasu, E.; Inoue, M.; Utsumi, K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. NMR 1990, 22, 27-38.
140. Scheidegger, R.; Pande, A. K.; Bounds, P. L.; Koppenol, W. H. The reaction of peroxynitrite with zeaxanthin. Nitric Oxide 1998, 2, 8-16.
141. Miyashita, K. Function of marine carotenoids. Forum Nutr. 2009, 61, 136-146.
142. Asai, A.; Yonekura, L.; Nagao, A. Low bioavailability of dietary epoxyxanthophylls in humans. Br. J. Nutr. 2008, 100, 273-277.
143. Mordenti, J. Man versus beast: Pharmacokinetic scalling in mammals. J. Pharm. Sci. 1986, 75, 1028-1040.
144. Maeda, H.; Hosokawa, M.; Sashima, T.; Funayama, K.; Miyashita, K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J. Agric. Food Chem. 2007, 55, 7701-7706.
145. Maeda, H.; Hosokawa, M.; Sashima, T.; Miyashita, K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J. Oleo Sci. 2007, 56, 615-621.
146. Beppu, F.; Niwano, Y.; Tsukui, T.; Hosokawa, M.; Miyashita, K. Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice. J. Toxicol. Sci. 2009, 34, 501-510.
147. Iio, K.; Okada, Y.; Ishikura, M. Single and 13-week oral toxicity study of fucoxanthin oil from microalgae in rats. Shokuhin Eiseigaku Zasshi 2011, 52, 183-189.
148. Maeda, H.; Hosokawa, M.; Sashima, T.; Funayama, K.; Miyashita, K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun. 2005, 332, 392-397.
149. Maeda, H.; Hosokawa, M.; Sashima, T.; Murakami-Funayama, K.; Miyashita, K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep. 2009, 2, 897-902.
150. Woo, M. N.; Jeon, S. M.; Kim, H. J.; Lee, M. K.; Shin, S. K.; Shin, Y. C.; Park, Y. B.; Choi, M. S. Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Chem. Biol. Interact. 2010, 186, 316-322.
151. Jeon, S. M.; Kim, H. J.; Woo, M. N.; Lee, M. K.; Shin, Y. C.; Park, Y. B.; Choi, M. S. Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice. Biotechnol. J. 2010, 5, 961-969.
152. Hosokawa, M.; Miyashita, T.; Nishikawa, S.; Emi, S.; Tsukui, T.; Beppu, F.; Okada, T.; Miyashita, K. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch. Biochem. Biophys. 2010, 504, 17-25.
153. Gammone, M. A; D'Orazio, N. Anti-obesity activity of the marine carotenoid fucoxanthin. Mar. Drugs 2015, 13, 2196-2214.
154. Matsumoto, M.; Hosokawa, M.; Matsukawa, N.; Hagio, M.; Shinoki, A.; Nishimukai, M.; Miyashita, K.; Yajima, T.; Hara, H. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Eur. J. Nutr. 2010, 49, 243-249.
155. Gammone, M. A; Gemello, E.; Riccioni, G.; D'Orazio, N. Marine bioactives and potential application in sports. Mar. Drugs 2014, 12, 2357-2382.
156. D'Orazio, N.; Gammone, M. A.; Gemello, E., De Girolamo, M.; Cusenza, S.; Riccioni, G. Marine bioactives: Pharmacological properties and potential applications against inflammatory diseases. Mar. Drugs 2012, 10, 812-833.
157. El-Agamey, A.; Lowe, G. M.; McGarvey, D. J.; Mortensen, A.; Phillip, D. M.; Truscott, T. G.; Young, A. J. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. Biochem. Biophys. 2004, 430, 37-48.
158. Woodall, A. A.; Britton, G.; Jackson M. J. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: Relationship between carotenoid structure and protective ability. Biochim. Biophys. Acta 1997, 1336, 575-586.
159. Tso, M. O. M.; Lam, T. T. Method of Retarding and Ameliorating Central Nervous System and Eye Damage. U. S. Patent 5527533, 18 June 1996.
160. Hussein, G.; Nakamura, M.; Zhao, Q.; Iguchi, T.; Goto, H.; Sankawa, U.; Watanabe, H. Antihypertensive and neuroprotective effects of astaxanthin experimental animals. Biol. Pharm. Bull. 2005, 28, 47-52.
161. Moreau, D.; Tomasoni, C.; Jacquot, C.; Kaas, R.; Le Guedes, R.; Cadoret, J. P.; Müller-Feuga, A.; Kontiza, I.; Vagias, C.; Roussis, V.; et al. Cultivated microalgae and the carotenoid fucoxanthin from Odontella aurita as potent anti-proliferative agents in bronchopulmonary and epithelial cell lines. Environ. Toxicol. Pharmacol. 2006, 22, 97-103.
162. Kawee-ai, A.; Kuntiya, A.; Kim, S. M. Anticholinesterase and antioxidant activities of fucoxanthin purified from the microalga Phaeodactylum tricornutum. Nat. Prod. Commun. 2013, 8, 1381-1386.
163. Soontornchaiboon, W.; Joo, S. S.; Kim, S. M. Anti-inflammatory effects of violaxanthin isolated from microalga Chlorella ellipsodea in RAW 264.7 macrophages. Biol. Pharmacol. Bull. 2012, 35, 1137-1144.
164. Eichler, O.; Sies, H.; Stahl, W. Divergent optimum levels of lycopene, β-carotene and lutein protecting against UVB irradiation in human fibroblast. Photochem. Photobiol. 2002, 75, 503-506.
165. Palozza, P.; Calviello, G.; Serini, S.; Maggiano, N.; Lanza, P.; Ranelletti, F. O.; Bartoli, G. M. β-Carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radic. Biol. Med. 2001, 30, 1000-1007.
166. Lowe, G. M.; Booth, L. A.; Young, A. J.; Bilton, R. F. Lycopene and β-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic. Res. 1999, 30, 141-151.
167. Le Tutour, B.; Benslimane, F.; Gouleau, M. P.; Gouygou, J. P.; Saadan, B.; Quemeneur, F. Antioxidant and prooxidant activities of the brown algae, Laminaria digitata, Himanthalia elongata, Fucus vesiculosus, Fucus serratus and Ascophyllum nodosum. J. Appl. Phycol. 1998, 10, 121-129.
168. Li, T. L.; King, J. M.; Min, D. B. Quenching mechanisms and kinetics of carotenoids in riboflavin photosensitized singlet oxygen oxidation of vitamin D2. J. Food Biochem. 2000, 24, 477-492.
169. McNulty, H. P.; Byun, J.; Lockwood, S. F.; Jacob, R. F.; Mason, R. P. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim. Biophys. Acta 2007, 1768, 167-174.
170. McNulty, H. P.; Jacob, R. F.; Mason, R. P. Biologic activity of carotenoids related to distinct membrane physicochemical interactions. Am. J. Cardiol. 2008, 101, 20-29.